Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents | Zendy

Thomas A. Mavrakanas | Zendy; Yiannis S. Chatzizisis | Zendy; Karim Gariani | Zendy; Larry S. Dean | Zendy; Giuseppe Gargiulo | Zendy; Gérard Helft | Zendy; Martine Gilard | Zendy; Fausto Feres | Zendy; Ricardo A. Costa | Zendy; Marie-Claude Morice | Zendy; JeanLouis Georges | Zendy; Marco Valgimigli | Zendy; Deepak L. Bhatt | Zendy; Laura Mauri | Zendy; David M. Charytan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents

Author(s) -

Thomas A. Mavrakanas,

Yiannis S. Chatzizisis,

Karim Gariani,

Larry S. Dean,

Giuseppe Gargiulo,

Gérard Helft,

Martine Gilard,

Fausto Feres,

Ricardo A. Costa,

Marie-Claude Morice,

JeanLouis Georges,

Marco Valgimigli,

Deepak L. Bhatt,

Laura Mauri,

David M. Charytan

Publication year - 2019

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.12901018

Subject(s) - medicine , relative risk , confidence interval , randomized controlled trial , drug eluting stent , myocardial infarction , incidence (geometry) , adverse effect , stent , platelet aggregation inhibitor , stroke (engine) , subgroup analysis , cardiology , percutaneous coronary intervention , surgery , aspirin , physics , optics , mechanical engineering , engineering

Whether prolonged dual antiplatelet therapy (DAPT) is more protective in patients with CKD and drug-eluting stents compared with shorter DAPT is uncertain. The purpose of this meta-analysis was to examine whether shorter DAPT in patients with drug-eluting stents and CKD is associated with lower mortality or major adverse cardiovascular event rates compared with longer DAPT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research